No Detail Found!

Remimazolam tosilate infusion has a lower incidence of hypotension than propofol infusion during painless colonoscopy

Author(s)
Sitong Li Department of Anesthesiology, Sinopharm Dongfeng General Hospital, Shiyan City 442000, Hubei Province, China.
Yi Zhang Department of Anesthesiology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi City 445000, Hubei Province, China.
Hongbai Wang Department of Anesthesiology, Fuwai hospital, Chinese Academy of medical Sciences and Peking Union Medical College, Beijing 100000, China.
Gang Ye Department of Anesthesiology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi City 445000, Hubei Province, China.
Nana Yao Department of Anesthesiology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi City 445000, Hubei Province, China.
Xianlin Zhu Department of Anesthesiology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi City 445000, Hubei Province, China.
Abstract
Background: Remimazolam tosilate is an ultra-short-acting sedative drug with the advantages of rapid onset and recovery, mild respiratory, and circulatory inhibition. This study primarily investigated the effect of remimazolam on incidence of intraoperative hypotension compared to the widely used propofol in patients undergoing outpatient painless colonoscopy. Methodology: This was a double-blinded, randomized, controlled trial. We randomly divided the eligible patients with outpatient appointment for painless colonoscopy in our hospital into the remimazolam group and the propofol group. The modified observer's assessment of alert/sedative was used to evaluate the depth of the patient's sedation. The Narcotrend score was monitored throughout the whole process. In the propofol group, propofol 0.5 -1.5 mg/kg was infused intravenously as a loading dose, followed by 3 -5 mg/kg/h to maintain a satisfied sedation depth during operation. While, with regarding to the patients in remimazolam grou p, remimazolam 0.05-0.15 mg/kg was induced intravenously as a loading dose, and continuously pumped at a rate of 0.3-0.5 mg/kg /h. SPSS 23.0 software was used to analyze the data. Results: From December 2020 to March 2021, we enrolled 116 eligible patients. The incidence of hypotension during sedation (13.8%) in the remimazolam group was significantly lower than that in propofol (37.9%), and the success rate of remimazolam (98.3%) was slightly lower than propofol (100.0%), but the awakening time was significantly shorter (P < 0.001); The incidence of respiratory inhibition, nausea, vomiting and other adverse events during colonoscopy, remimazolam was significantly lower than that of propofol (P < 0.05). Conclusion: Remimazolam tosilate still has higher circulatory stability than propofol in painless colonoscopy under continuous administration with a loading dose. Trial registration: The trial was registered at the Chinese Clinical Trial Registry (ChiCTR2000040557), data of registration: December 2020. Abbreviations: BMI- Body Mass Index; MOAA/S- Modified Observer’s Assessment of Alert Scale; MAP- Mean Arterial Pressure; Rem- Remimazolam; Pro- Propofol
Publication Details
Page(s) 697-705
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 27, Issue: 6, Year: 2023

Request the full text from PASTIC

Keywords
Propofol, Hypotension, Painless Colonoscopy, Remimazolam tosilate
References
Gastroenterol .2019 .. , 14 : 89-103.
.2018 .. , : .
.2017 .and mortality. Gut, 66 : 683-691.
. .. -310912, : .
Ahmed M. Colon . .Cancer: A Clinician's Perspective in 2019.. , : .
Res Gastroenterology .2020 .. , 13 : 1-10.
Shi X,Chen X,Ni J,Zhang Y,Liu H,Xu C .2022 .Systematic review and meta-analysis of the prognostic value of Narcotrend monitoring of different depths of anesthesia and different Bispectral Index (BIS) values for cognitive dysfunction after tumor surgery in elderly patients. Ann Transl Med, 10 : 186.
Chen S,Wang J,Xu X,Huang Y,Xue S,Wu A .2020 .The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positivecontrolled, phase III clinical trial. Am J Transl Res, 12 : 4594-4603.
Chung F,Chan VW,Ong D. . .A post-anesthetic discharge scoring system for home readiness after ambulatory surgery. J Clin Anesth. 1995 Sep;7, (95) : 00130-a.
Sneyd JR,Absalom AR,Barends CRM,Jones JB .2021 .Hypotension during propofol sedation for colonoscopy: a retrospective exploratory analysis and meta-analysis. Br J Anaesth, 10 : 610-622.
ao L,Hu X,Zhu B,Li W,Huang X,Kang F. .2020 .Clinical observation of the combined use of propofol and etomidate in painless gastroscopy. Medicine (Baltimore), 99 : e23061.
ahinovic MM,Struys MMRF,Absalom AR .2018 .. Clinical Pharmacokinetics and Pharmacodynamics of Propofol. Clin Pharmacokinet, 57 : 1539-1558.
Zhu X,Wang H,Yuan S,Li Y,Jia Y,Zhang Z . .Efficacy and Safety of Remimazolam in Endoscopic Sedation-A Systematic. , : .
.2021 .. , 8 : 655042.
Xu Y,Zheng Y,Tang T,Chen L,Zhang Y .2022 .The effectiveness of esketamine and propofol versus dezocine and propofol sedation during gastroscopy: A randomized controlled study. J Clin Pharm Ther, 47 : 1402-1408.
Ozgul U,Begec Z,Karahan K,Ali Erdogan M,Said Aydogan M,Colak C .2013 .Comparison of Propofol and Ketamine-Propofol Mixture (Ketofol) on Laryngeal Tube-Suction II Conditions and Hemodynamics: A Randomized, Prospective, Double-Blind Trial. Curr Ther Res Clin Exp, 06 : 39-43.
im KM .2022 .Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesth Pain Med, 17 : 1-11.
Schüttler J,Eisenried A,Lerch M,Fechner J,Jeleazcov C,Ihmsen H C .2020 .Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics. Anesthesiology, 132 : 636-651.
Liu T,Lai T,Chen J,Lu Y,He F,Chen Y .2021 .Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: A randomized, doubleblind, controlled trial. Pharmacol Res Perspect, 9 : e00851.
Chen X,Xin D,Xu G,Zhao J,Lv Q. .2022 .The Efficacy and Safety of Remimazolam Tosilate Versus Dexmedetomidine in Outpatients Undergoing Flexible Bronchoscopy: A Prospective, Randomized, Blind, Non-Inferiority Trial. Front Pharmacol, 13 : 902065.
Chen SH,Yuan TM,Zhang J,Bai H,Tian M,Pan CX .2021 .Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase III trial. J Gastroenterol Hepatol, 36 : 474-481.
Borkett KM,Riff DS,Schwartz HI,Winkle PJ,Pambianco DJ,Lees JP .2015 .A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Anesth Analg, 120 : 771-80.
0

Citations

0

Downloads

43

Views